Q: Why has the stock price of DOC dropped so dramatically from July 5, 2021 at 2.32 down to current 1.60?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I have been watching this company for some time. It also has a good dividend. I am thinking of buying now and i realize it is at an annual high. What are your thoughts?
-
BioCryst Pharmaceuticals Inc. (BCRX)
-
G1 Therapeutics Inc. (GTHX)
-
Myovant Sciences Ltd. (MYOV)
-
TG Therapeutics Inc. (TGTX)
Q: Hi 5i,
Need help narrowing this list down to two stocks. Which ones have the best earning or projected earnings and balance sheets. Also what are the analysts saying any additional information is appreciated. Do you have any other ideas for small biotech?
Regards,
Need help narrowing this list down to two stocks. Which ones have the best earning or projected earnings and balance sheets. Also what are the analysts saying any additional information is appreciated. Do you have any other ideas for small biotech?
Regards,
Q: Can you please give me your thought on ABBV . Is it a good buy at USD 110 and what caused the stock to sell off ?
Thank you
Thank you
Q: You noted several months ago that Johnson and Johnson may have exposure from opioid lawsuits and that this may be of concern. ABBV, through its Allergen division, may also be involved in at least some of these suits. You have continued to recommend ABBV so do you feel they are less exposed?
Appreciate your insight.
Paul F.
Appreciate your insight.
Paul F.
Q: We would like your opinion on AXSM:US for 4% long term position.
Thanks
Thomas
Thanks
Thomas
Q: What is your opinion of VentriPoint at this time. Stock has been going up with some inside buying. Thank you for your research.
Q: What is your opinion on Labs.
Thanks
Thanks
Q: I realize this company has not been public for long but what are your thoughts about taking a position?
Q: With the Caisse de depot acquiring a large US health care staffing company, do you see a potential in it buying PHA, a health care staffing company in its own backyard?
Q: Abbvie keeps getting sold off. Down another 2.5% today. Do you think it has bottomed after the steep slide over the past 10 days or so? Would this be a good entry point?
Q: What does it mean to well to be added to the tsx comp index.
Q: What do you think of the future of BETR?
Q: I own both the above ETF’s, down approximately 33% on both. I am ready to be patient with them. Do you see any compelling reason in the cannabis market to keep holding them, or would you take your losses?
Thanks
Thanks
Q: any idea why this co is trading so poorly. I know the share float is quite limited but has recently had insider buying and share buybacks. Looks like they have made some good acquisitions since IPO. Thanks
Q: thanks for Thursday's Market Update...the narrative and charts put reduced tapering with interest rate increases clearly in front of me...and now is making me wonder, especially about a possible window of opportunity later in the year, if I should wait until later to top up to full positions in ISRG and SYK, both heath care US stocks in a LIRA and to be held for the long-term, or do it now....what would you suggest I do or consider?.....oh, the funds used would move health care closer to the Portfolio Analytic target for this sector........thanks for the insights....Tom
Q: What do you think of the acquisition?
Thanks
Thanks
Q: TRUL ... with recent activities and target stock prices from many brokerages between $96 to $85 ... is this undervalued and is this a good buy at this price
Q: I don't see anything posted on last night's results so I will ask for your comments on the quarter
Q: hello 5i:
We've held GUD since 2014; one of the very few losers in a mostly, 5i recommended and diverse portfolio. Its shrunk to a less than 1% holding. Would you now be fine letting this go to add to a 1.5% position in WELL, realizing there may be a valuation difference? Thanks for your good work over the years. hello 5I:
just asked this question and should have included other health care holdings so you could assess properly. MRK, ABBV and VEEV in equal amounts. WELL at a smaller position. Please include this info with my previous question when answering.
thanks
Paul L
Paul L
We've held GUD since 2014; one of the very few losers in a mostly, 5i recommended and diverse portfolio. Its shrunk to a less than 1% holding. Would you now be fine letting this go to add to a 1.5% position in WELL, realizing there may be a valuation difference? Thanks for your good work over the years. hello 5I:
just asked this question and should have included other health care holdings so you could assess properly. MRK, ABBV and VEEV in equal amounts. WELL at a smaller position. Please include this info with my previous question when answering.
thanks
Paul L
Paul L